Analysis of thrombogenicity in patients with cardiovascular disease

Analysis of thrombogenicity in patients with cardiovascular disease - Thrombogenicity and CVD

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000017228

Enrollment

500

Registered

2015-04-21

Start date

2014-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular disease

Interventions

The presence and absence of cardiovascular disease The presence and absence of medications

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. The presence and absence of cardiovascular disease 2. Age is 20 years old or more. 3. Patients who gave their informed consent to participate for the present study.

Exclusion criteria

Exclusion criteria: 1.Ineligible patients according to the judgment by physician

Design outcomes

Primary

Measure	Time frame
Associations between major cardiac events or effects of various treatments and thrombogenicity.	—

Secondary

Measure	Time frame
Associations between the presence or absence of CVD and thrombogenicity. Associations between major cardiac events or the effects of various treatments and thrombogenicity.	—

Countries

Japan

Contacts

Public ContactShin-ichiro Miura

Fukuoka University School of Medicine Department of Cardiology

miuras@cis.fukuoka-u.ac.jp81-92-801-1011

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026